"Ketamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
| Descriptor ID |
D007649
|
| MeSH Number(s) |
D02.455.426.392.368.367.652
|
| Concept/Terms |
Ketamine- Ketamine
- 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
|
Below are MeSH descriptors whose meaning is more general than "Ketamine".
Below are MeSH descriptors whose meaning is more specific than "Ketamine".
This graph shows the total number of publications written about "Ketamine" by people in this website by year, and whether "Ketamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 1 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 9 | 1 | 10 |
| 2018 | 12 | 3 | 15 |
| 2019 | 6 | 0 | 6 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Ketamine" by people in Profiles.
-
Ketamine-induced cholangiopathy in ARDS patients. Intensive Care Med. 2021 10; 47(10):1173-1174.
-
Intravenous Ketamine for Cancer Pain Management, Including Flares During the COVID-19 Pandemic: A Retrospective Study. Pain Med. 2021 07 25; 22(7):1642-1650.
-
Real-world effectiveness of repeated ketamine infusions for treatment resistant depression during the COVID-19 pandemic. Psychiatry Res. 2021 09; 303:114086.
-
Reply to: "Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered". J Hepatol. 2021 10; 75(4):990-992.
-
Unconscious gender bias in academic publications. Indian J Ophthalmol. 2021 06; 69(6):1635-1636.
-
Ketamine-Induced Sclerosing Cholangitis (KISC) in a Critically Ill Patient With COVID-19. Hepatology. 2021 07; 74(1):519-521.
-
Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered. J Hepatol. 2021 10; 75(4):989-990.
-
Resurgence of combined intravenous Ketamine and regional anesthesia in pediatric ocular surgery in COVID-19 pandemic. Indian J Ophthalmol. 2021 Feb; 69(2):395-399.
-
Perspectives of Ketamine Use in COVID-19 Patients. J Korean Med Sci. 2021 Jan 25; 36(4):e28.
-
[Psychiatry]. Rev Med Suisse. 2021 Jan 13; 17(720-1):85-89.